Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation.
Claudio Piqueras-SanchezMaría Asunción Esteve-PastorJorge Moreno-FernandezEva Soler-EspejoJose Miguel Rivera-CaravacaVanessa RoldánFrancisco MarínPublished in: Expert review of neurotherapeutics (2024)
Following an ICH event in an anticoagulated patient, a comprehensive clinical evaluation is imperative. Anticoagulation should be promptly withdrawn and reversed. Once the patient is stabilized, a reintroduction of anticoagulation should be considered, typically within a timeframe of 4-8 weeks, if feasible. If re-anticoagulation is not possible, alternative options such as Left Atrial Appendage Occlusion are available.